Crowded top management, high salaries, high wastes, overstocking, poor receipts and total mismanagement. Future is very bleak and we only have the management to blame. A lot of trust was put on the CEO who has dissapointed us and destroyed all of our investment. We are certainly heading towards the worst negative profit fy.
Ann: Cellmid's Evolis Patent to be Granted in China, page-23
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.768M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.6¢ | $11.31K | 1.886M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1650000 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 915710 | 1 |
View Market Depth
| Last trade - 14.23pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.6¢ |
Change
0.000 ( 14.3 %) |
||||
| Open | High | Low | Volume | ||
| 0.6¢ | 0.6¢ | 0.6¢ | 287949 | ||
| Last updated 14.34pm 14/06/2024 ? | |||||
| AN1 (ASX) Chart |